PASI, Psoriasis Area and Severity Index

Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis
Helena Marzo-Ortega, Dennis McGonagle, Laura A Rhodes, Ai Lyn Tan, Philip G Conaghan, Philip O’Connor, Steven F Tanner, Alexander Fraser, Douglas Veale, Paul Emery

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 778-781; DOI: 10.1136/ard.2006.063818
Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience
Paraskevi V Voulgari, Aliki I Venetsanopoulou, Efstratios K Epagelis, Yannis Alamanos, Ioanna Takalou, Alexandros A Drosos

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 270-271; DOI: 10.1136/ard.2006.058735
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
D D Gladman, P J Mease, M A Cifaldi, R J Perdok, E Sasso, J Medich

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 163-168; DOI: 10.1136/ard.2006.057901
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni, G G Krueger, K de Vlam, C Birbara, A Beutler, C Guzzo, B Zhou, L T Dooley, A Kavanaugh

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1150-1157; DOI: 10.1136/ard.2004.032268

Main menu